ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
abrdn Life Sciences Investors

abrdn Life Sciences Investors (HQL)

16,92
-0,35
(-2,03%)
Geschlossen 06 Juni 10:00PM
17,00
0,08
(0,47%)
Nach Börsenschluss: 1:56AM

abrdn Life Sciences Investors (HQL) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
17,00
( -1,56% )
Gebot
-
Fragen
-
Volumen
127.018
16,5901 Tagesbereich 17,285
12,34 52-Wochen-Bereich 18,46
Marktkapitalisierung
Handelsende
17,27
Handelsbeginn
17,25
Letzte Trade
291
@
16.92
Letzter Handelszeitpunkt
Finanzvolumen
US$ 2.167.021
VWAP
17,0607
Durchschnittliches Volumen (3 Mio.)
US$ 107.071
Ausgegebene Aktien
30.408.047
Dividendenrendite (LTM)
1,82 (11,00%)
Kurs-Gewinn-Verhältnis
6,18
Gewinn pro Aktie (EPS)
2,89
Erlöse (LTM)
1,94M
Nettogewinn (LTM)
85,59M

Über abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics,... Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Mehr anzeigen

Sektor
Finance
Branche
Asset Management Services
Hauptsitz
Philadelphia, United States
Gegründet
1992
abrdn Life Sciences Investors is listed in the Finance sector of the New York Börse with ticker HQL. The last closing price for abrdn Life Sciences Inve... was US$17,27. Over the last year, abrdn Life Sciences Inve... shares have traded in a share price range of US$ 12,34 to US$ 18,46.

abrdn Life Sciences Inve... currently has 30.408.047 shares in issue. The market capitalisation of abrdn Life Sciences Inve... is US$516,94 million. abrdn Life Sciences Inve... has a price to earnings ratio (PE ratio) of 6.18.

HQL Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.76-4.2792792792817.7617.9116.6410101717.29671331CS
4-1.03-5.712701053818.0318.4616.4410594917.60269509CS
120.352.102102102116.6518.4615.819410163517.27548166CS
26-0.29-1.6772700983217.2918.4615.6611790217.03751009CS
524.4335.242641209212.5718.4612.3413369515.96626671CS
1563.42513.618.4610.550111591014.41617728CS
260-3.04-15.169660678620.0422.710.550110122615.07215636CS

HQL - Frequently Asked Questions (FAQ)

What is the current abrdn Life Sciences Investors share price?
The current share price of abrdn Life Sciences Investors is US$ 17,00
How many abrdn Life Sciences Investors shares are in issue?
abrdn Life Sciences Investors has 30.408.047 shares in issue
What is the market cap of abrdn Life Sciences Investors?
The market capitalisation of abrdn Life Sciences Investors is USD 516,94M
What is the 1 year trading range for abrdn Life Sciences Investors share price?
abrdn Life Sciences Investors has traded in the range of US$ 12,34 to US$ 18,46 during the past year
What is the PE ratio of abrdn Life Sciences Investors?
The price to earnings ratio of abrdn Life Sciences Investors is 6,18
What is the cash to sales ratio of abrdn Life Sciences Investors?
The cash to sales ratio of abrdn Life Sciences Investors is 280,17
What is the registered address of abrdn Life Sciences Investors?
The registered address for abrdn Life Sciences Investors is 1900 Market Street, Philadelphia, Pennsylvania, 19103
Which industry sector does abrdn Life Sciences Investors operate in?
abrdn Life Sciences Investors operates in the Asset Management Services sector

HQL Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen